Indo French Biotech Enterprises Ltd Financial Statement

As of Jun 15, 2025, Indo French Biotech Enterprises Ltd has a market capitalization of - Cr. Value Research classifies it as a Mega-Cap company.

Yes, Indo French Biotech Enterprises Ltd is not with a debt-to-equity ratio of .

In FY 2024 , Indo French Biotech Enterprises Ltd recorded a total revenue of approximately - Cr marking a significant milestone in the company's financial performance.

Indo French Biotech Enterprises Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising annually..

Indo French Biotech Enterprises Ltd's current PE ratio is .

Indo French Biotech Enterprises Ltd's ROCE averaged NaN% from the FY ending March NaN to NaN, with a median of NaN%. It peaked at -Infinity% in March NaN, reflecting strong capital efficiency over the period..

Indo French Biotech Enterprises Ltd's latest EBIT is Rs. - Cr, surpassing the average EBIT of Rs. - Cr over the 5 years..